- Home
- THTX vs PMVP Comparison
THTX vs PMVP Comparison
Compare THTX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- PMVP
- Stock Information
- Founded
- THTX 1993
- PMVP 2013
- Country
- THTX Canada
- PMVP United States
- Employees
- THTX N/A
- PMVP N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- THTX Health Care
- PMVP Health Care
- Exchange
- THTX Nasdaq
- PMVP Nasdaq
- Market Cap
- THTX 93.3M
- PMVP 85.5M
- IPO Year
- THTX N/A
- PMVP 2020
- Fundamental
- Price
- THTX $1.72
- PMVP $1.37
- Analyst Decision
- THTX Hold
- PMVP Strong Buy
- Analyst Count
- THTX 1
- PMVP 3
- Target Price
- THTX N/A
- PMVP $5.33
- AVG Volume (30 Days)
- THTX 178.5K
- PMVP 175.1K
- Earning Date
- THTX 02-19-2025
- PMVP 02-27-2025
- Dividend Yield
- THTX N/A
- PMVP N/A
- EPS Growth
- THTX N/A
- PMVP N/A
- EPS
- THTX N/A
- PMVP N/A
- Revenue
- THTX $84,316,000.00
- PMVP N/A
- Revenue This Year
- THTX $5.78
- PMVP N/A
- Revenue Next Year
- THTX $2.47
- PMVP N/A
- P/E Ratio
- THTX N/A
- PMVP N/A
- Revenue Growth
- THTX 5.75
- PMVP N/A
- 52 Week Low
- THTX $1.08
- PMVP $1.32
- 52 Week High
- THTX $2.18
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- THTX 50.28
- PMVP 33.56
- Support Level
- THTX $1.69
- PMVP $1.32
- Resistance Level
- THTX $1.83
- PMVP $1.50
- Average True Range (ATR)
- THTX 0.13
- PMVP 0.07
- MACD
- THTX -0.04
- PMVP -0.01
- Stochastic Oscillator
- THTX 19.30
- PMVP 16.61
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.